This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SHOW MORE Discover the innovative Borderline PersonalityDisorder Inventory (BPD-I™), a psychodynamically-informed tool for assessing BPD symptoms effectively. Наталья Добровольска/AdobeStock Borderline personalitydisorder (BPD) remains one of the most commonly misunderstood and challenging diagnoses in mental health.
Related Videos Related Content Advertisement June 13th 2025 Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score John J. Newsletter Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients. Subscribe Now!
Emerging research on RNA biomarkers, AI applications, and genetic mutations shows promise for developing new diagnostic tools for bipolardisorder. Non-pharmacological approaches and combination therapies are emphasized in treatment, with recent FDA approvals for new medications targeting bipolar symptoms.
Related Videos Related Content Advertisement June 6th 2025 Brief Book Reviews: June 2025 Edmund S. Gold, MD, MS May 5th 2025 Brief Book Reviews: May 2025 Edmund S. Higgins, MD April 8th 2025 Lorazepam and the White Lotus in our Tariff Times H.
The second quarter of 2025 saw some huge successes and fails in the psychiatric treatment pipeline. What percentage of 2025 Q2 psychiatric pipeline news was positive vs negative? Learn more in this exclusive article.
Maguire, MD , Heidi Anne Duerr, MPH Maguire discussed the differential diagnosis of bipolar depression at the Southern California Psychiatry Conference. Similarly, because patients with bipolardisorder often self-medicate, looking for a family history of substance abuse can be helpful. “iI's
June 23, 2025. September 11, 2025. With MDMA on hold, what’s next for psychedelics? Psychiatric Times. link] Newsletter Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients. Subscribe Now!
July 8, 2025. sNDA submitted: lumateperone as adjunctive therapy for major depressive disorder. Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo. News release. Psychiatric Times. December 3, 2024.
She has been on an antipsychotic medication to treat her bipolardisorder for 10 years, resulting in stability of mood symptoms that were previously poorly controlled. How can this be? Let’s review a few case examples. Case 1 “Ms Robbins” is 49 years old and works as a bank teller.
June 30, 2025. Accessed July 1, 2025. children and adolescents in 2022: diagnosis, severity, co-occurring disorders, and treatment. FDA requires expanded labeling about weight loss risk in patients younger than 6 years taking extended-release stimulants for ADHD. FDA Drug Safety Communication. CDC Growth Charts. September 2024.
Accessed June 11, 2025. Author(s): Joseph F. Goldberg, MD , Stephen M. Stahl, MD, PhD, DSc (Hon) Now more than ever, capturing and scaling the ingredients that make for compelling and impactful teaching for trainees is vital to our future. Division of Clinical Pharmacology, Indiana University School of Medicine Updated 2021.
Related Videos Related Content Advertisement July 3rd 2025 Young Researchers Featured at Conference of Society for Digital Mental Health Kenneth J. Author(s): Leah Kuntz Brush up on your reading before you attend the Southern California Psychiatry Conference!
Sanom/Adobestock BREAKING NEWS The US Food and Drug Administration granted Transcend Therapeutics with the Breakthrough Therapy designation for their compound TSND-201 for (methylone) for the treatment of posttraumatic stress disorder (PTSD) following positive results from its IMPACT-1 study.
FDA Officially Eliminates Clozapine REMS On June 13, 2025, the US Food and Drug Administration (FDA) officially eliminated the clozapine REMS, and all REMS operations ceased. AminaDesign/AdobeStock Take a look at this month’s developments in the psychiatric treatment pipeline.
Related Videos Related Content Advertisement June 17th 2025 ADHD With BipolarDisorder: Genetics, Diagnosis, and New Thinking on Treatment David N. Subscribe Now!
NRx is targeting suicidal depression and PTSD with NRX-100, anticipating an FDA decision by the end of 2025. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.
Presented at: Southern California Psychiatry Conference; July 11-12, 2025; Huntington Beach, CA. Accessed July 11, 2025. January 21, 2025. Positive Results for Dextromethorphan-Bupropion ASCEND Phase 2 Clinical Trial. Psychiatric Times. May 19, 2022. Psychiatric Times.
Related Videos Related Content Advertisement June 17th 2025 ADHD With BipolarDisorder: Genetics, Diagnosis, and New Thinking on Treatment David N. Subscribe Now!
Some participants in the MDD group had other diagnoses along with MDD: 8 had a form of personalitydisorder, 3 had posttraumatic stress disorder, 2 had alcohol abuse issues, 1 had social phobia, 1 had somatoform disorder, 1 had trichotillomania, and 2 had previous psychotic symptoms.
Related Videos Related Content Advertisement June 17th 2025 ADHD With BipolarDisorder: Genetics, Diagnosis, and New Thinking on Treatment David N. Subscribe Now!
Presented at: Southern California Psychiatry Conference ; July 11-12, 2025; Huntington Beach, CA. Accessed July 11, 2025. Accessed July 11, 2025. Neurosteroid Therapeutics “Offer Great Promise” in Postpartum Depression. Psychiatric Times. December 4, 2023. FDA Approves First Oral Treatment for Postpartum Depression in Adults.
A Harmful Dysfunction Analysis Author(s): Jean-Arthur Micoulaud-Franchi, MD, PhD , Christophe Gauld, MD, PhD +2 More Key Takeaways Sleep medicine lacks a structured definition for disorders, complicating diagnosis and classification compared to psychiatry's DSM framework. Subscribe Now! Siddiqui, BSc Shizuka Tomatsu, MD Matthew J.
Related Videos Related Content Advertisement July 3rd 2025 Ode to Self-Compassion Frank A. Berlin, MD June 14th 2025 An Ageless Dream Frank A. Berlin, MD May 14th 2025 "Transference" Richard M. Berlin, MD April 18th 2025 In or Out Frank A. Clark, MD July 21st 2016 The Hang Gliders Richard M.
Steven Moffic, MD Series | Psychiatric Views on the Daily News Key Takeaways Rising disorder prevalence and reduced resources challenge psychiatry amidst social crises, leading to emotional overwhelm. Related Videos Related Content Advertisement July 14th 2025 Overcoming Disaster Fatigue, Part 1: The Challenges H.
Accessed July 1, 2025. Dr Robinson is assistant professor and director of the Psychiatric-Mental Health Nurse Practitioner specialty at the University of Maryland School of Nursing. References 1. Pregnancy and lactation labeling final rule. Yue M, Kus L, Katta S, et al. Pharmacokinetics of antidepressants in pregnancy. J Clin Pharmacol.
A 1989 publication by psychiatry icons Gelenberg et al 8 convincingly demonstrated that for maintenance treatment of patients with bipolardisorder with a serum lithium concentration of 0.4 mmol/L, there was a 2.6 times greater relapse risk than patients with a serum lithium concentration of 0.8
Accessed June 3, 2025. Accessed June 3, 2025. July 1, 2024. Nakagawa K, Yellowlees P. Inter-generational effects of technology: why millennial physicians may be less at risk for burnout than baby boomers. Curr Psychiatry Rep. 2020;22(9):45. Defining “technology.” October 12, 2024. Industrial revolution. Encyclopædia Britannica.
Related Videos Related Content Advertisement June 5th 2025 Enhancement Psychiatry H. Steven Moffic, MD June 3rd 2025 Whither Psychiatry? Steven Moffic, MD June 2nd 2025 The Psychiatrist Ethics of “Take Care of Yourself and Each Other” H. Steven Moffic, MD May 30th 2025 DEI Concerns in Psychiatric Organizations H.
Related Videos Related Content Advertisement June 16th 2025 If You Were a Cookie, What Kind Would You Be? Berlin, MD May 15th 2025 You could have killed me today Jaslyn Kindel, MD December 13th 2012 Last Concert of the Summer (Podcast) Richard M. Berlin, MD April 18th 2025 In or Out Frank A. Clark, MD April 17th 2025 Bad Debts.
Related Videos Related Content Advertisement June 10th 2025 Rallying for Public and Immigrant Mental Health Amidst the Parading of Military Might H. Steven Moffic, MD June 6th 2025 Redemption in Psychiatry H. Steven Moffic, MD June 5th 2025 Enhancement Psychiatry H. Steven Moffic, MD June 3rd 2025 Whither Psychiatry?
Following the SIPS assessment in a sample of 141 adolescents, results showed that 44% of participants were diagnosed with a UHR syndrome, 42% were diagnosed with full psychosis, and 13% did not receive a diagnosis within the psychotic spectrum.
McIntyre, MD, FRCPC Key Takeaways Incretin-based treatments, especially GLP-1 RAs, may address comorbidities in mental disorders and have direct CNS effects, potentially modifying disease progression. J Affect Disord. BipolarDisord. The GLP-1 RAs as Psychiatric Medications? The GLP-1 RAs as Psychiatric Medications?
Accessed June 13, 2025. Steven Moffic, MD Series | Psychiatric Views on the Daily News Key Takeaways Redemption in psychiatry involves acknowledging failures and striving for improvement, extending beyond religious contexts. He serves on the Editorial Board of Psychiatric Times. References 1. Brian Wilson — a powerful interview.
Ben Gingell/AdobeStock On July 17, 2025, the 988 National Suicide & Crisis Lifeline will stop providing tailored support options to LGBTQ+ youth and young adults. SHOW MORE LGBTQ+ youth face increased suicide risks as vital support services are cut, prompting urgent calls for Congress to reverse this dangerous decision.
Could some of the characters meet criteria for bipolardisorder? Posttraumatic stress disorder? Higgins, MD Explore transformative memoirs and insights on estrangement in these 2 brief book reviews. From a clinical lens, the book offers a buffet of psychopathology. Depression? Quite possibly.
Gratefully, it not only goes on in my Milwaukee, but should be increased in recognition because it is also included for the first time in the large and beloved SummerFest music events, as discussed in the June 3, 2025, article in the Milwaukee Journal Sentinel “Americans need transformative talks on race. Juneteenth is the space for that.”
Related Videos Related Content Advertisement July 10th 2025 TSND-201 Receives Breakthrough Therapy Designation From FDA for PTSD Heidi Anne Duerr, MPH September 28th 2021 A Forensic Psychiatrist Takes the Stand James L. Clark, MD A psychiatrist reflects on the recent flooding tragedy in Texas. Subscribe Now!
Steven Moffic, MD Prevention of wars would reduce the extraordinary loss of lives and major trauma. This video series is taking a short break while Dr Moffic travels.
Mcintyre, MD, FRCPC Key Takeaways GLP-1 and GIP are key incretins involved in glucoregulation, with GLP-1 RAs showing significant therapeutic potential in T2DM and beyond. Subscribe Now!
Park Street Press; 2025. Steven Moffic, MD Are you ready for new reading recommendations related to psychiatry? This video series is taking a short break while Dr Moffic travels. In addition, I mention my own serendipities often and a leading psychiatrist authority of them just came out with his own memoir: Bernard Beitman, MD.
Author(s): Psychiatric Times Editors Key Takeaways H. Steven Moffic, MD, examines death, dying, past lives, and the afterlife, linking them to mental health.
Related Videos Related Content Advertisement June 17th 2025 ADHD With BipolarDisorder: Genetics, Diagnosis, and New Thinking on Treatment David N. Subscribe Now!
CONFERENCE REPORTER Psychiatric clinicians supporting patients with dementia-related agitation have faced significant challenges, without US Food and Drug Administration-approved options and restrictive warnings on commonly used treatments, explained Gerald Maguire, MD, at the 2025 Southern California Psychiatry Conference.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content